![Dag Nesse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dag Nesse
Chief Tech/Sci/R&D Officer at
ABLIVA AB
Profile
Dag Nesse is currently the Vice President-Clinical Operations at Abliva AB. Previously, he held positions as the Director-Clinical Operations at EpiEndo Pharmaceuticals ehf, the Head-Clinical Operations at Modus Therapeutics AB, and the Head-Clinical Operations at Calliditas Therapeutics AB. Mr. Nesse completed his undergraduate studies at the University of Oslo and BI Norwegian Business School.
Dag Nesse active positions
| Companies | Position | Start |
|---|---|---|
| ABLIVA AB | Chief Tech/Sci/R&D Officer | 2023-01-31 |
Former positions of Dag Nesse
| Companies | Position | End |
|---|---|---|
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Chief Tech/Sci/R&D Officer | - |
| CALLIDITAS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | - |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Chief Tech/Sci/R&D Officer | - |
Training of Dag Nesse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Dag Nesse
